default author photo

Payam Tabarsi

Shahid Beheshti University of Medical Sciences

Tehran

Iran

  • Shahid Beheshti University of Medical Sciences

SCHOLARLY PAPERS

1

DOWNLOADS

181

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunogenicity and Safety of a Variant-Specific COVID-19 Vaccine Booster, BIV1-Coviran Plus: Findings from a Non-Inferiority, Parallel-Design Non-Randomised Clinical Trial

Number of pages: 18 Posted: 13 Aug 2022
Minoo Mohraz, Mohsen Abbasi-Kangevari, Seyyed-Hadi Ghamari, Erfan Ghasemi, Mohammad-Reza Malekpour, Negar Rezaei, Ali Zare Dehnavi, Ensiyeh Rahimi, Naser Ahmadi, Sahar Saeedi Moghaddam, Payam Tabarsi, Asghar Abdoli, Mohammadreza Salehi and Hamed Hosseini
Tehran University of Medical Sciences, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran University of Medical Sciences, Tehran University of Medical Sciences, Tehran University of Medical Sciences - Non-Communicable Diseases Research Center, Shahid Beheshti University of Medical Sciences, Pasteur Institute of Iran, Tehran University of Medical Sciences and Tehran University of Medical Sciences
Downloads 181 (418,025)

Abstract:

Loading...

Omicron, Clinical trial, COVID-19 control, non-inferiority, immunogenicity, Inactivated